Clinical Audit on Uterine Closure During Caesarean Section in Assiut Women's Health Hospital

January 17, 2025 updated by: Lobna Hassan Ahmed AbdelRhman, Assiut University
Auditing of closure of uterine incision in Caesarean section in Assiut Women's Health Hospital.

Study Overview

Status

Not yet recruiting

Study Type

Observational

Enrollment (Estimated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All elective Caeserean sections with no medical or obestetric disorder

Description

Inclusion Criteria:

  • all elective Caesarean section

Exclusion Criteria:

  1. Placenta previa
  2. Chorioamionitis
  3. PROM
  4. Diabetic women
  5. Immunocompromised women
  6. Women with heart disease
  7. Women with renal or liver disease
  8. Women on corticosteroids therapy
  9. Preeclampsia
  10. Women with hypertensive disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improve performance of closure of Caesarean section. in Assiut Women health hospital according to NICE guidelines and National Library of Medicine
Time Frame: Through study completion an average of one year
Questionaire
Through study completion an average of one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Decrease complications of caeserean section
Time Frame: Through study completion an average of one year
Questionaire
Through study completion an average of one year
Training of university staff
Time Frame: Through study completion an average of one year
Questionaire
Through study completion an average of one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 1, 2025

Primary Completion (Estimated)

January 1, 2026

Study Completion (Estimated)

May 1, 2026

Study Registration Dates

First Submitted

December 22, 2024

First Submitted That Met QC Criteria

January 17, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 17, 2025

Last Verified

December 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • Uterus closure

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Uterine Closure in Caesarean Section

Subscribe